.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Please enable Javascript to use all features and improve your user experience.

Adam Strzelczyk

Engagements

19/09/2024

12:00 – 13:00
Session Industry
Industrial Symposium UCB Pharma GmbH
Pro and contra of invasive therapies for the treatment of LGS
Lecture hall 1
12:30 – 13:00 30 Min. 0 Min.
Other
Anti-seizure medications remain the mainstay of therapy in LGS
15:30 – 17:00
International Epilepsy Colloquium
Epilepsy surgery by aetiology III
Lecture hall 1

20/09/2024

11:00 – 11:30 20 Min. 10 Min.
Lecture
Unknown Case 10
12:00 – 12:04 4 Min. 0 Min.
Poster
eP 18
Real-world experience of cannabidiol in conjunction with clobazam for the treatment of seizures associated with Lennox-Gastaut syndrome and Dravet syndrome: Results from a retrospective multicentre study in Germany
Treatment of drug refractory epilepsy